XML 41 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Investments (Tables)
9 Months Ended
Sep. 30, 2025
Investments, Debt and Equity Securities [Abstract]  
Schedule of Investments in Debt Securities
The Company’s investments in debt securities consisted of the following as of September 30, 2025 and December 31, 2024 (in thousands):
September 30, 2025
 CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
Corporate bonds$16,474 $20 $(1)$16,493 
Total debt securities$16,474 $20 $(1)$16,493 
Included in cash and cash equivalents$— $— $— $— 
Included in marketable securities$16,474 $20 $(1)$16,493 
December 31, 2024
 CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
U.S. treasury securities$10,933 $22 $— $10,955 
Commercial paper19,067 — 19,074 
Corporate bonds81,207 166 (16)81,357 
Certificate of deposits1,561 — — 1,561 
Total debt securities$112,768 $195 $(16)$112,947 
Included in cash and cash equivalents$16,280 $$— $16,285 
Included in marketable securities$96,488 $190 $(16)$96,662 
Schedule of Gross Unrealized Losses and Fair Value of Debt Securities in Unrealized Loss Position
The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of September 30, 2025 and December 31, 2024 (in thousands):
September 30, 2025December 31, 2024
Gross
Unrealized
Losses
Fair ValueGross
Unrealized
Losses
Fair Value
Corporate bonds$(1)$4,503 $(16)$31,546 
Total$(1)$4,503 $(16)$31,546 
Schedule of Equity Investments
The Company’s equity investments consisted of the following as of September 30, 2025 and December 31, 2024 (in thousands):
Condensed Consolidated Balance Sheets LocationSeptember 30, 2025December 31, 2024
Money market funds(1)
Cash and cash equivalents$21,277 $17,730 
Marketable equity investments(1)
Marketable securities3,015 3,165 
Investment in non-marketable securities(2)
Other non-current assets10,000 10,000 
Total$34,292 $30,895 
(1)    Investments with readily determinable fair values.
(2)    Investment in privately held company without readily determinable fair value.